Ching Ngar Wong

TISIDB: an integrated repository portal for tumor-immune system interactions

Beibei Ru, Jiangwen Zhang, Yin Tong, 2019, Bioinform..

CR2Cancer: a database for chromatin regulators in human cancer

Yin Tong, Jianlong Sun, Aditi Chandra, 2017, Nucleic Acids Res..

Title CR 2 Cancer : a database for chromatin regulators in humancancer

Ching Ngar Wong, Acacia Tsz So Tang, Jiangwen Zhang, 2017 .

MICMIC: identification of DNA methylation of distal regulatory regions with causal effects on tumorigenesis

Ching Ngar Wong, Jiangwen Zhang, S. Leung, 2018, Genome Biology.

Qualification of tumour mutational burden by targeted next‐generation sequencing as a biomarker in hepatocellular carcinoma

Ching Ngar Wong, C. Avellini, R. Goldin, 2020, Liver international : official journal of the International Association for the Study of the Liver.

Applicability of Routine Targeted Next-generation Sequencing to Estimate Tumor Mutational Burden (TMB) in Patients Treated With Immune Checkpoint Inhibitor Therapy

Ching Ngar Wong, R. Ratnakumaran, D. Pinato, 2019, Journal of immunotherapy.

Immune-based therapies for hepatocellular carcinoma

Ching Ngar Wong, L. Rimassa, Rohini Sharma, 2020, Oncogene.

C-terminal truncated HBx initiates hepatocarcinogenesis by downregulating TXNIP and reprogramming glucose metabolism

Ching Ngar Wong, P. Sham, X. Guan, 2020, Oncogene.

Phenotypic Characteristics of the Tumour Microenvironment in Primary and Secondary Hepatocellular Carcinoma

Ching Ngar Wong, A. Akarca, T. Marafioti, 2021, Cancers.

A phase Ib study of pembrolizumab following trans-arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): PETAL

Ching Ngar Wong, A. Akarca, T. Marafioti, 2019, Annals of Oncology.